Francois Kerendi is a seasoned professional in business and commercial operations, currently serving as the Vice President at CureVac since 2021. Previously, Francois held various leadership roles at GlaxoSmithKline, including Director and Head of Business & Commercial Analysis, and at Merck as Senior Director of Global Commercial Development. Their education includes a Master of Business Administration from the University of Manchester and a Bachelor of Arts from the State University of New York at Stony Brook, alongside an additional MBA from Indiana University.
This person is not in any teams
This person is not in any offices